PortalPublikationenSevere COVID-19-associated myocarditis with cardiogenic shoc...

Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review

Standard

Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review. / Noone, Stephanie; Flinspach, Armin N; Fichtlscherer, Stephan; Zacharowski, Kai; Sonntagbauer, Michael; Raimann, Florian J.

in: BMC ANESTHESIOL, Jahrgang 22, Nr. 1, 385, 12.12.2022.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Noone, S, Flinspach, AN, Fichtlscherer, S, Zacharowski, K, Sonntagbauer, M & Raimann, FJ 2022, 'Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review', BMC ANESTHESIOL, Jg. 22, Nr. 1, 385. https://doi.org/10.1186/s12871-022-01890-4

APA

Noone, S., Flinspach, A. N., Fichtlscherer, S., Zacharowski, K., Sonntagbauer, M., & Raimann, F. J. (2022). Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review. BMC ANESTHESIOL, 22(1), [385]. https://doi.org/10.1186/s12871-022-01890-4

Vancouver

Noone S, Flinspach AN, Fichtlscherer S, Zacharowski K, Sonntagbauer M, Raimann FJ. Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review. BMC ANESTHESIOL. 2022 Dez 12;22(1). 385. https://doi.org/10.1186/s12871-022-01890-4

Bibtex

@article{b83384382816441183236b036289181a,
title = "Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review",
abstract = "BACKGROUND: Primary viral myocarditis associated with severe acute respiratory syndrome coronavirus 2 (SARS-Cov2) infection is a rare diagnosis.CASE PRESENTATION: We report the case of an unvaccinated, healthy patient with cardiogenic shock in the context of a COVID-19-associated myocarditis and therapy with simultaneous veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and percutaneous left ventricular decompression therapy with an Impella. The aim of this review is to provide an overview of therapeutic options for patients with COVID-19-associated myocarditis.CONCLUSIONS: The majority of patients required a combination of two assist devices to achieve sufficient cardiac output until recovery of left ventricular ejection fraction. Due to the rapid onset of this fulminant cardiogenic shock immediate invasive bridging therapy in a specialized center was lifesaving.",
keywords = "Humans, Shock, Cardiogenic/etiology, Heart-Assist Devices, Stroke Volume, RNA, Viral, Ventricular Function, Left, COVID-19/complications, SARS-CoV-2, Myocarditis/complications",
author = "Stephanie Noone and Flinspach, {Armin N} and Stephan Fichtlscherer and Kai Zacharowski and Michael Sonntagbauer and Raimann, {Florian J}",
note = "{\textcopyright} 2022. The Author(s).",
year = "2022",
month = dec,
day = "12",
doi = "10.1186/s12871-022-01890-4",
language = "English",
volume = "22",
journal = "BMC ANESTHESIOL",
issn = "1471-2253",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review

AU - Noone, Stephanie

AU - Flinspach, Armin N

AU - Fichtlscherer, Stephan

AU - Zacharowski, Kai

AU - Sonntagbauer, Michael

AU - Raimann, Florian J

N1 - © 2022. The Author(s).

PY - 2022/12/12

Y1 - 2022/12/12

N2 - BACKGROUND: Primary viral myocarditis associated with severe acute respiratory syndrome coronavirus 2 (SARS-Cov2) infection is a rare diagnosis.CASE PRESENTATION: We report the case of an unvaccinated, healthy patient with cardiogenic shock in the context of a COVID-19-associated myocarditis and therapy with simultaneous veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and percutaneous left ventricular decompression therapy with an Impella. The aim of this review is to provide an overview of therapeutic options for patients with COVID-19-associated myocarditis.CONCLUSIONS: The majority of patients required a combination of two assist devices to achieve sufficient cardiac output until recovery of left ventricular ejection fraction. Due to the rapid onset of this fulminant cardiogenic shock immediate invasive bridging therapy in a specialized center was lifesaving.

AB - BACKGROUND: Primary viral myocarditis associated with severe acute respiratory syndrome coronavirus 2 (SARS-Cov2) infection is a rare diagnosis.CASE PRESENTATION: We report the case of an unvaccinated, healthy patient with cardiogenic shock in the context of a COVID-19-associated myocarditis and therapy with simultaneous veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and percutaneous left ventricular decompression therapy with an Impella. The aim of this review is to provide an overview of therapeutic options for patients with COVID-19-associated myocarditis.CONCLUSIONS: The majority of patients required a combination of two assist devices to achieve sufficient cardiac output until recovery of left ventricular ejection fraction. Due to the rapid onset of this fulminant cardiogenic shock immediate invasive bridging therapy in a specialized center was lifesaving.

KW - Humans

KW - Shock, Cardiogenic/etiology

KW - Heart-Assist Devices

KW - Stroke Volume

KW - RNA, Viral

KW - Ventricular Function, Left

KW - COVID-19/complications

KW - SARS-CoV-2

KW - Myocarditis/complications

U2 - 10.1186/s12871-022-01890-4

DO - 10.1186/s12871-022-01890-4

M3 - SCORING: Journal article

C2 - 36503438

VL - 22

JO - BMC ANESTHESIOL

JF - BMC ANESTHESIOL

SN - 1471-2253

IS - 1

M1 - 385

ER -